##reference=GRCh38
##referenceURI=GRCh38
# locus	type	ref	length	genotype	filter	pvalue	phred_qual_score	cnv_pvalue	coverage	allele_coverage	allele_ratio	allele_frequency_%	maf	hrun	som_pval	gene	transcript	location	function	codon	exon	protein	coding	sift	polyphen	grantham	normalizedAlt	5000Exomes	FATHMM	NamedVariants	clinvar	cosmic	dbsnp	dgv	dra	drugbank	go	omim	pfam	phylop	dra_20170914	GRCh38_clinvar_20201226	GRCh38_cosmic_92	GRCh38_dbsnp_154	GRCh38_dgv_20200225	GRCh38_drugbank_20201029	GRCh38_esp6500_20151203	GRCh38_go_20201118	GRCh38_namedVariants_20151113	GRCh38_omim_20201202	GRCh38_pfam_33	GRCh38_phylop_20151118	GRCh38_refgene_201	MyVariantDefaultDb_GRCh38
chr1:11791061	SNV	A	1	G/G	PASS	3.0803495365425044E-81	805.114		82	A=0,G=82	A=0.0,G=1.0	100.00	0.098	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1752+146T>C				G						rs7518348		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.08														
chr1:11794400	SNV	G	1	A/A	PASS	1.0329992352432281E-99	989.859		99	G=0,A=99	G=0.0,A=1.0	100.00	0.097	1		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	TTT	8	p.Phe435=	c.1305C>T				A	GMAF=0.1095:AMAF=0.3173:EMAF=0.003			Benign		rs756018487:rs4846051		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.65														
chr1:11794698	SNV	G	1	A/A	PASS	5.6493697481231496E-217	2162.48		224	G=2,A=222	G=0.0089,A=0.9911	99.11	0.421	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1166+31C>T				A	GMAF=0.4642:AMAF=0.4346:EMAF=0.4124					rs1994798		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-4.42														
chr1:11801426	SNV	G	1	G/A	PASS	3.1938903336759056E-8	74.9568		98	G=69,A=29	G=0.7041,A=0.2959	29.59		2		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.237-27C>T				A						rs1377686341		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		1.2														
chr1:23808231	SNV	T	1	C/C	PASS	4.852885001621289E-251	2503.14		250	T=0,C=250	T=0.0,C=1.0	100.00	0.113	1		HMGCL	NM_000191.3	HMGCL:exonic:NM_000191.3	synonymous	CTG	7	p.Leu218=	c.654A>G				C	GMAF=0.0737:AMAF=0.039:EMAF=0.0915			Benign		rs719400		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	1.23														
chr1:23817442	SNV	A	1	G/G	PASS	1.140249787561137E-154	1539.43		157	A=0,G=157	A=0.0,G=1.0	100.00	0.112	1		HMGCL	NM_000191.3	HMGCL:intronic:NM_000191.3	unknown			p.?	c.252+34T>C				G	GMAF=0.0735:AMAF=0.039:EMAF=0.0912			Benign		rs2076344		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	-1.17														
chr1:45508256	SNV	G	1	A/A	PASS	1.8793168168032724E-127	1267.26		134	G=2,A=132	G=0.0149,A=0.9851	98.51	0.475	1		MMACHC	NM_015506.3	MMACHC:exonic:NM_015506.3	synonymous	GTA	3	p.Val107=	c.321G>A				A	GMAF=0.4162:AMAF=0.3723:EMAF=0.437	0.12		Benign	6288212	rs2275276		(dui:NBS9;dis:Organic Acid Condition;g:MMACHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMACHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMACHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMACHC)(dui:NBS2;dis:Core Conditions;g:MMACHC)(dui:NBS57;dis:Homocystinuria;g:MMACHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMACHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMACHC)(dui:D008659;dis:Metabolic Diseases;g:MMACHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMACHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMACHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMACHC)(dui:D009748;dis:Nutrition Disorders;g:MMACHC)(dui:D044342;dis:Malnutrition;g:MMACHC)(dui:D003677;dis:Deficiency Diseases;g:MMACHC)(dui:D020138;dis:Hyperhomocysteinemia;g:MMACHC)(dui:D001361;dis:Avitaminosis;g:MMACHC)(dui:D014804;dis:Vitamin B Deficiency;g:MMACHC)(dui:D009422;dis:Nervous System Diseases;g:MMACHC)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MMACHC)(dui:D002493;dis:Central Nervous System Diseases;g:MMACHC)(dui:D003240;dis:Connective Tissue Diseases;g:MMACHC)(dui:D001927;dis:Brain Diseases;g:MMACHC)(dui:D001928;dis:Brain Diseases, Metabolic;g:MMACHC)(dui:D006712;dis:Homocystinuria;g:MMACHC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MMACHC)(dui:D014806;dis:Vitamin B 12 Deficiency;g:MMACHC)(dui:D005128;dis:Eye Diseases;g:MMACHC)(dui:D012164;dis:Retinal Diseases;g:MMACHC)(dui:D012162;dis:Retinal Degeneration;g:MMACHC)(dui:D008268;dis:Macular Degeneration;g:MMACHC)	Hydroxocobalamin:Cyanocobalamin	GO:0071949:GO:0042803:GO:0032451:GO:0009235:GO:0005515:GO:0043295:GO:0005737:GO:0016491:GO:0006749:GO:0031419:GO:0005829:GO:0055114:GO:0016740:GO:0070988:GO:0033787	609831	PF16690	-0.88														
chr1:75728369	SNV	C	1	C/G	PASS	1.336595516546435E-31	308.74		112	C=51,G=61	C=0.4554,G=0.5446	54.46	0.183	1		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.31-32C>G				G	GMAF=0.2535:AMAF=0.1614:EMAF=0.3007			Benign		rs7524467		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.31														
chr1:75728544	INDEL	GT	1	G/G	PASS	2.4945947269429866E-96	956.03		147	GT=0,G=147	GT=0.0,G=1.0	100.00	0.0	4		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+57delT				G				Benign		rs1454388372:rs75993895:rs1173791164:rs796117827		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.2,0.0														
chr1:75728621	SNV	A	1	G/G	PASS	2.3496328208483577E-141	1406.29		145	A=1,G=144	A=0.0069,G=0.9931	99.31	0.104	2		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+133A>G				G						rs1146572		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-0.18														
chr1:75732751	SNV	T	1	T/C	PASS	6.823386941416634E-35	341.66		125	T=57,C=68	T=0.456,C=0.544	54.40	0.231	1		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.216+10T>C				C	GMAF=0.3176:AMAF=0.292:EMAF=0.3307			Benign		rs2275378		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-0.01														
chr1:75733100	SNV	G	1	G/A	PASS	1.44977297542215E-59	588.387		239	G=114,A=125	G=0.477,A=0.523	52.30	0.231	1		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.286+178G>A				A	GMAF=0.3193:AMAF=0.29:EMAF=0.3322			Benign		rs3818855		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.64														
chr1:75733660	SNV	C	1	C/G	PASS	1.261827534590668E-40	398.99		160	C=77,G=83	C=0.4813,G=0.5188	51.88	0.231	1		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.387+32C>G				G	GMAF=0.3174:AMAF=0.2912:EMAF=0.3308			Benign		rs2153126		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-1.39														
chr1:75739958	SNV	C	1	C/A	PASS	2.814491879812151E-25	245.506		139	C=78,A=61	C=0.5612,A=0.4388	43.88	0.19	1		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.469-22C>A				A	GMAF=0.2589:AMAF=0.1791:EMAF=0.2997			Benign		rs12127402		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.23														
chr1:75761337	SNV	A	1	A/G	PASS	2.0021656215890275E-28	276.985		99	A=45,G=54	A=0.4545,G=0.5455	54.55	0.174	1		ACADM	NM_000016.6	ACADM:exonic:NM_000016.6	synonymous	GTG	11	p.Val387=	c.1161A>G				G	GMAF=0.25:AMAF=0.1589:EMAF=0.2966	0.75		Benign	5038163	rs1061337:rs748826784		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	1.28														
chr1:100206504	SNV	T	1	C/C	PASS	1.7418068733915E-311	3107.59		313	T=0,C=313	T=0.0,C=1.0	100.00	0.108	1		DBT	NM_001918.5	DBT:exonic:NM_001918.5	missense	GGT	9	p.Ser384Gly	c.1150A>G	1.0	0.0	56.0	C	GMAF=0.1408:AMAF=0.2251:EMAF=0.0976			Benign		rs12021720		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	1.94														
chr1:100218774	INDEL	AGT	2	A/AGAT	PASS	1.1714938148790538E-10	99.3126		18	AGT=1,A=4,AGAT=13	AGT=0.0556,A=0.2222,AGAT=0.7222	A=22.22,AGAT=72.22		1,0		DBT	NM_001918.5	DBT:intronic:NM_001918.5	unknown|unknown	|		p.?|p.?	c.434-29_434-28delAC|c.434-29_434-28insT	|	|	|	A|GA						rs764699299:rs751965796:rs1391098440		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	2.4,0.39,0.29														
chr1:100218784	INDEL	AAATTT	4	AA/AAT	PASS	1.377526619605168E-15	148.609		19	AAATTT=0,A=4,AA=8,AAA=1,AAT=5,AT=1	AAATTT=0.0,A=0.2105,AA=0.4211,AAA=0.0526,AAT=0.2632,AT=0.0526	A=21.05,AA=42.11,AAA=5.26,AAT=26.32,AT=5.26	0.001	8,8,12,8,8		DBT	NM_001918.5	DBT:intronic:NM_001918.5	unknown|unknown	|		p.?|p.?	c.434-42_434-39delAAAT|c.434-41_434-39delAAT	|	|	|	A|A						rs79284286:rs1029078439:rs539500540		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	0.16,0.48,0.36,-0.39,-0.1,-0.13														
chr1:115033402	SNV	A	1	A/G	PASS	6.619116119411294E-39	381.792		143	A=66,G=77	A=0.4615,G=0.5385	53.85	0.016	1		TSHB	NM_000549.5	TSHB:exonic:NM_000549.5	missense	GCA	2	p.Thr14Ala	c.40A>G	0.32	0.0	58.0	G	GMAF=0.0248:AMAF=0.0057:EMAF=0.0345			Benign		rs10776792		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TSHB)(dui:NBS2;dis:Core Conditions;g:TSHB)(dui:NBS12;dis:Endocrine Disorder;g:TSHB)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TSHB)(dui:D004700;dis:Endocrine System Diseases;g:TSHB)(dui:D013959;dis:Thyroid Diseases;g:TSHB)(dui:D007037;dis:Hypothyroidism;g:TSHB)(dui:D009140;dis:Musculoskeletal Diseases;g:TSHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TSHB)(dui:D001847;dis:Bone Diseases;g:TSHB)(dui:D001849;dis:Bone Diseases, Endocrine;g:TSHB)(dui:D004392;dis:Dwarfism;g:TSHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:TSHB)(dui:D001848;dis:Bone Diseases, Developmental;g:TSHB)(dui:D003409;dis:Congenital Hypothyroidism;g:TSHB)(dui:D009422;dis:Nervous System Diseases;g:TSHB)(dui:D001523;dis:Mental Disorders;g:TSHB)(dui:D000068105;dis:Bipolar and Related Disorders;g:TSHB)(dui:D009461;dis:Neurologic Manifestations;g:TSHB)(dui:D001714;dis:Bipolar Disorder;g:TSHB)(dui:D019954;dis:Neurobehavioral Manifestations;g:TSHB)(dui:D003244;dis:Consciousness Disorders;g:TSHB)(dui:D014474;dis:Unconsciousness;g:TSHB)(dui:D003128;dis:Coma;g:TSHB)		GO:0005615:GO:0043627:GO:0007186:GO:0005737:GO:0051592:GO:0007267:GO:0009653:GO:0016486:GO:0033189:GO:0005576:GO:0005179:GO:0009755	188540		0.21														
chr2:1423168	SNV	G	1	G/T	PASS	4.704354057259793E-31	303.275		141	G=73,T=68	G=0.5177,T=0.4823	48.23	0.054	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.179+39G>T				T	GMAF=0.0123:AMAF=0.0343:EMAF=0.001					rs28909374		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-4.09														
chr2:1433391	SNV	A	1	A/C	PASS	3.84414711759579E-32	314.152		175	A=97,C=78	A=0.5543,C=0.4457	44.57	0.399	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.180-47A>C				C	GMAF=0.3166:AMAF=0.4721:EMAF=0.237					rs1473936		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.5														
chr2:1433432	SNV	C	1	C/A	PASS	3.335799966620502E-31	304.768		172	C=96,A=76	C=0.5581,A=0.4419	44.19	0.05	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.180-6C>A				A	GMAF=0.0073:AMAF=0.0195:EMAF=0.001	0.06		Benign	4001203	rs78253418		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.98														
chr2:1433638	SNV	C	1	C/T	PASS	5.0361655743608243E-26	252.979		139	C=77,T=62	C=0.554,T=0.446	44.60	0.437	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.349+31C>T				T	GMAF=0.4955:AMAF=0.2935:EMAF=0.4009					rs4927578		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.12														
chr2:1456034	SNV	A	1	G/G	PASS	1.4743479830613583E-86	858.314		87	A=0,G=87	A=0.0,G=1.0	100.00	0.065	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.613-42A>G				G	GMAF=0.0716:AMAF=0.104:EMAF=0.055					rs4927610:rs1036271161		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.86														
chr2:1477383	SNV	G	1	G/T	PASS	7.094144004534059E-17	161.491		75	G=39,T=36	G=0.52,T=0.48	48.00	0.408	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCG	8	p.Ala373Ser	c.1117G>T	1.0	0.005	99.0	T	GMAF=0.4069:AMAF=0.3165:EMAF=0.4479	0.03		Benign	3749597	rs2280132		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.12														
chr2:1477459	SNV	G	1	C/C	PASS	1.0303861204416285E-119	1189.87		119	G=0,C=119	G=0.0,C=1.0	100.00	0.29	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	ACC	8	p.Ser398Thr	c.1193G>C	0.05	0.999	58.0	C	GMAF=0.2184:AMAF=0.1362:EMAF=0.2602	0.89		Benign	1579950	rs2175977		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	1.05														
chr2:1484559	SNV	C	1	C/A	PASS	2.254239212152437E-22	216.47		103	C=54,A=49	C=0.5243,A=0.4757	47.57	0.002	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1339-37C>A				A	GMAF=8.0E-4:AMAF=0.0025:EMAF=0.0					rs373327555		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.5														
chr2:1484823	SNV	T	1	T/C	PASS	3.3946890538007794E-22	214.692		67	T=28,C=39	T=0.4179,C=0.5821	58.21	0.019	3		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	GCC	9	p.Ala522=	c.1566T>C				C	GMAF=0.0167:AMAF=0.0488:EMAF=2.0E-4			Benign/Likely benign		rs17091745		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.12														
chr2:1484842	SNV	T	1	T/C	PASS	2.870780582024704E-20	195.42		66	T=29,C=37	T=0.4394,C=0.5606	56.06	0.019	2		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	CTA	9	p.Leu529=	c.1585T>C				C	GMAF=0.0161:AMAF=0.047:EMAF=2.0E-4	0.55		Benign	716480	rs114401108:rs386642298		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.18														
chr2:1484844	SNV	A	1	A/C	PASS	2.896009618851714E-20	195.382		66	A=29,C=37	A=0.4394,C=0.5606	56.06	0.019	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TTC	9	p.Leu529Phe	c.1587A>C	0.0	0.732	22.0	C	GMAF=0.0165:AMAF=0.0484:EMAF=2.0E-4			Benign/Likely benign		rs114796303:rs386642298		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.02														
chr2:1484896	SNV	T	1	T/C	PASS	8.982557377294137E-21	200.466		64	T=27,C=37	T=0.4219,C=0.5781	57.81	0.403	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+42T>C				C	GMAF=0.4494:AMAF=0.3093:EMAF=0.4789					rs6715129		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.34														
chr2:1484941	SNV	T	1	T/C	PASS	5.1820309200722835E-18	172.855		46	T=17,C=29	T=0.3696,C=0.6304	63.04	0.019	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+87T>C				C						rs140382650		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.23														
chr2:1496155	SNV	A	1	A/C	PASS	1.2481592511599826E-10	99.0373		56	A=32,C=24	A=0.5714,C=0.4286	42.86	0.498	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	CCT	12	p.Thr725Pro	c.2173A>C	1.0	0.0	38.0	C	GMAF=0.4703:AMAF=0.3926:EMAF=0.4001	0.03		Benign	3812428	rs732609		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	2.92														
chr2:1516904	SNV	T	1	T/C	PASS	4.744604320607667E-44	433.238		143	T=61,C=82	T=0.4266,C=0.5734	57.34	0.336	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	GCG	15	p.Val847Ala	c.2540T>C	1.0	0.0	64.0	C	GMAF=0.3867:AMAF=0.2288:EMAF=0.4677	0		Benign	148793	rs1126799		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.63														
chr2:1542555	SNV	C	1	C/G	PASS	7.719692476102496E-33	321.124		176	C=97,G=79	C=0.5511,G=0.4489	44.89	0.353	2		TPO	NM_000547.5	TPO:utr_3:NM_000547.5	unknown		17	p.?	c.*81C>G				G	GMAF=0.3815:AMAF=0.2384:EMAF=0.4437	0		Benign	4001255	rs1042589		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.2														
chr2:149571002	SNV	C	1	C/T	PASS	3.7359409225879846E-22	214.276		37	C=8,T=29	C=0.2162,T=0.7838	78.38	0.378	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.696+83G>A				T						rs4500908		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.28														
chr2:149575863	SNV	C	1	C/G	PASS	5.638972803349504E-20	192.488		120	C=70,G=50	C=0.5833,G=0.4167	41.67	0.378	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-22G>C				G	GMAF=0.3774:AMAF=0.3115:EMAF=0.2178			Likely benign		rs12232959		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-2.14														
chr2:149575955	SNV	G	1	G/T	PASS	1.9116131087399768E-16	157.186		122	G=76,T=46	G=0.623,T=0.377	37.70	0.369	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-114C>A				T						rs10932467		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.8														
chr2:149576462	SNV	C	1	C/T	PASS	2.7201947619843968E-42	415.654		135	C=57,T=78	C=0.4222,T=0.5778	57.78	0.24	1		MMADHC	NM_015702.3	MMADHC:exonic:NM_015702.3	synonymous	CAA	5	p.Gln151=	c.453G>A				T	GMAF=0.2261:AMAF=0.4839:EMAF=0.094	0.38		Benign	7128893	rs11545261		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.09														
chr2:149579375	INDEL	C	2	C/CAA	PASS	4.027170343254595E-12	113.95		118	C=61,CAA=57	C=0.5169,CAA=0.4831	48.31	0.352	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.372+55_372+56insTT				CAA						rs36108609:rs1573878596		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.05														
chr2:149587175	SNV	C	1	C/G	PASS	5.8708366939627395E-22	212.313		110	C=60,G=50	C=0.5455,G=0.4545	45.45	0.311	1		MMADHC|MMADHC-DT	NM_015702.3|NR_110240.1	MMADHC:intronic:NM_015702.3|MMADHC-DT:upstream:NR_110240.1	unknown|	|	|	p.?|	c.-52-26G>C|	|	|	|	G|	GMAF=0.2632:AMAF=0.3497:EMAF=0.0949					rs4667420		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.12														
chr3:49417897	SNV	C	1	C/T	PASS	9.132716996648155E-27	260.394		115	C=58,T=57	C=0.5043,T=0.4957	49.57	0.201	2		AMT	NR_028435.2	AMT:exonic_nc:NR_028435.2			8							GMAF=0.2889:AMAF=0.2408:EMAF=0.3136	0.9		Benign	4158145	rs11715915		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine		238310		0.89														
chr3:49421681	SNV	A	1	A/C	PASS	1.8745628243283807E-12	117.271		77	A=46,C=31	A=0.5974,C=0.4026	40.26	0.417	3		AMT|NICN1	NR_028435.2|NM_032316.3	AMT:intronic_nc:NR_028435.2|NICN1:downstream:NM_032316.3	|unknown	|	|	|p.?	|c.*3152T>G	|	|	|	|C						rs4855873		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine	GO:0005515:GO:0005654:GO:0005874	238310:611516		1.08														
chr3:183017394	SNV	C	1	A/A	PASS	2.716439268839067E-110	1095.66		111	C=0,A=111	C=0.0,A=1.0	100.00	0.047	1		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1978-57G>T				A	GMAF=0.0675:AMAF=0.065:EMAF=0.0685					rs6786878		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	-0.36														
chr3:183037179	SNV	A	1	A/G	PASS	1.667323993890566E-7	67.7798		57	A=37,G=20	A=0.6491,G=0.3509	35.09	0.103	4		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1594+39T>C				G	GMAF=0.0603:AMAF=0.1221:EMAF=0.0286			Benign		rs2270969		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	1.6														
chr3:183037421	SNV	T	1	G/G	PASS	3.0690219883911205E-176	1755.13		176	T=0,G=176	T=0.0,G=1.0	100.00	0.465	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	missense	CCC	13	p.His464Pro	c.1391A>C	0.01	0.0	77.0	G	GMAF=0.4152:AMAF=0.2876:EMAF=0.2629	0.92		Benign	4002526	rs2270968		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	1.12														
chr3:183072461	SNV	G	1	A/A	PASS	2.890679882365371E-125	1245.39		128	G=1,A=127	G=0.0078,A=0.9922	99.22	0.084	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	synonymous	CTT	5	p.Leu132=	c.396C>T				A	GMAF=0.1147:AMAF=0.2034:EMAF=0.0692			Benign		rs7622479		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	0.89														
chr4:145650988	SNV	G	1	G/A	PASS	3.6358001230014416E-24	234.394		123	G=67,A=56	G=0.5447,A=0.4553	45.53	0.277	2		MMAA	NM_001375644.1	MMAA:intronic:NM_001375644.1	unknown			p.?	c.734-74G>A				A						rs11721510		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAA)(dui:NBS2;dis:Core Conditions;g:MMAA)(dui:NBS9;dis:Organic Acid Condition;g:MMAA)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAA)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAA)(dui:D008659;dis:Metabolic Diseases;g:MMAA)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAA)	Hydroxocobalamin:Cyanocobalamin		607481		-0.22														
chr4:145651075	SNV	G	1	G/A	PASS	1.2061463307641095E-48	479.186		261	G=143,A=118	G=0.5479,A=0.4521	45.21	0.049	2		MMAA	NM_001375644.1	MMAA:exonic:NM_001375644.1	synonymous	TCA	5	p.Ser249=	c.747G>A				A	GMAF=0.0895:AMAF=0.0622:EMAF=0.1035	0.14		Benign	3760417	rs11721553		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAA)(dui:NBS2;dis:Core Conditions;g:MMAA)(dui:NBS9;dis:Organic Acid Condition;g:MMAA)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAA)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAA)(dui:D008659;dis:Metabolic Diseases;g:MMAA)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAA)	Hydroxocobalamin:Cyanocobalamin		607481		-1.51														
chr5:71626789	SNV	G	1	A/A	PASS	7.128530301265103E-107	1061.47		107	G=0,A=107	G=0.0,A=1.0	100.00	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.738+36G>A				A	GMAF=0.2032:AMAF=0.2797:EMAF=0.164			Benign		rs12516456		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-0.73														
chr5:71632256	SNV	C	1	T/T	PASS	1.0327614057614212E-109	1089.86		109	C=0,T=109	C=0.0,T=1.0	100.00	0.39	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.803+71C>T				T						rs277981		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.98														
chr5:71649248	SNV	A	1	G/G	PASS	6.0394862937638805E-142	1412.19		143	A=0,G=143	A=0.0,G=1.0	100.00	0.149	1		MCCC2	NM_022132.5	MCCC2:exonic:NM_022132.5	synonymous	GCG	14	p.Ala456=	c.1368A>G				G	GMAF=0.1868:AMAF=0.2935:EMAF=0.1321	0.07		Benign	4407210	rs10064079		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.2														
chr5:71652827	SNV	G	1	A/A	PASS	3.1405086938763195E-135	1345.03		138	G=1,A=137	G=0.0072,A=0.9928	99.28	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.1574+73G>A				A						rs2242372		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	0.28														
chr6:32038540	SNV	C	1	T/T	PASS	1.036573256767003E-18	179.844		20	C=1,T=19	C=0.05,T=0.95	95.00		2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	TTG	1	p.Leu40=	c.118C>T				T		0.61		Benign	4160891	rs6468		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.09														
chr6:32038560	SNV	C	1	C/A	PASS	7.716138244793743E-5	41.126		17	C=9,A=8	C=0.5294,A=0.4706	47.06		4		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CCA	1	p.Pro46=	c.138C>A				A		0.05		Benign	4160892	rs6464		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.44														
chr6:32038820	SNV	C	1	C/T	PASS	1.8866007380436894E-9	87.2432		22	C=8,T=14	C=0.3636,T=0.6364	63.64	0.288	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+9C>T				T				Benign		rs6462		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.82														
chr6:32038840	INDEL	TAAAAAAAT	3	TAAAAA/TAAAAAAT	PASS	6.126324544438677E-18	172.128		21	TAAAAAAAT=0,TAAAAA=9,TAAAAAA=1,TAAAAAAT=11	TAAAAAAAT=0.0,TAAAAA=0.4286,TAAAAAA=0.0476,TAAAAAAT=0.5238	TAAAAA=42.86,TAAAAAA=4.76,TAAAAAAT=52.38	0.218:0.0:0.003	7,7,7		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown|unknown	|		p.?|p.?	c.292+35_292+37delAAT|c.292+30delA	|	|	|	A|T						rs1329918756:rs1353476955:rs561284668:rs755425808:rs6463:rs746666047:rs184177366:rs777229786		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.59,0.23,0.64,-0.36,1.04,0.2,1.0,0.83,-0.79														
chr6:32038878	SNV	C	1	C/T	PASS	1.1940430909145846E-8	79.2298		29	C=14,T=15	C=0.4828,T=0.5172	51.72	0.218	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+67C>T				T						rs6449		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-2.74														
chr6:32039027	SNV	C	1	A/G	PASS	5.784955199650849E-35	342.377		39	C=2,A=16,G=21	C=0.0513,A=0.4103,G=0.5385	A=41.03,G=53.85	0.176	2,2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown|unknown	|		p.?|p.?	c.293-67C>A|c.293-67C>G	|	|	|	A|G						rs6451:rs1562756023		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.11														
chr6:32039046	SNV	A	1	A/G	PASS	2.280972240856881E-8	76.4188		38	A=21,G=17	A=0.5526,G=0.4474	44.74	0.038	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-48A>G				G	GMAF=0.0115:AMAF=0.0135:EMAF=0.0105					rs66933575:rs59064806		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	1.41														
chr6:32039050	SNV	G	1	G/T	PASS	2.2789773033335592E-8	76.4226		38	G=21,T=17	G=0.5526,T=0.4474	44.74	0.038	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-44G>T				T						rs66933575:rs6453		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.25														
chr6:32039055	MNV	CA	2	CA/GG	PASS	2.279922056153542E-8	76.4208		38	CA=21,GG=17	CA=0.5526,GG=0.4474	44.74	0.036	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-39_293-38delinsGG				GG						rs58256870:rs66933575:rs35147842:rs202093120		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.34,-0.29														
chr6:32039081	SNV	C	1	A/A	PASS	1.1119877424455667E-36	359.539		37	C=0,A=37	C=0.0,A=1.0	100.00	0.348	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-13C>A				A	GMAF=0.3707:AMAF=0.3445:EMAF=0.384			Conflicting interpretations of pathogenicity		rs6467:rs1267808195		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.23														
chr6:32039286	SNV	C	1	T/T	PASS	2.2263836295529074E-53	526.524		54	C=0,T=54	C=0.0,T=1.0	100.00	0.313	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.447+38C>T				T	GMAF=0.2787:AMAF=0.295:EMAF=0.2704			Benign		rs6466		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.86														
chr6:32039847	MNV	AC	2	AC/GT	PASS	5.487821792914582E-21	202.606		90	AC=46,GT=44	AC=0.5111,GT=0.4889	48.89	0.173:0.174	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.738+12_738+13delinsGT				GT	GMAF=0.034:AMAF=0.0545:EMAF=0.0235			Uncertain significance		rs193922547:rs6458:rs6459:rs1554305325:rs71552100		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.57,-3.0														
chr6:32040013	SNV	C	1	C/G	PASS	8.243279016759808E-4	30.839		35	C=25,G=10	C=0.7143,G=0.2857	28.57	0.214	1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CTG	7	p.Leu249=	c.747C>G				G		0.01		Benign	4003960	rs6477		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.02														
chr6:32040072	SNV	G	1	G/C	PASS	1.2782034929152256E-21	208.934		46	G=14,C=32	G=0.3043,C=0.6957	69.57	0.196	1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	missense	ACC	7	p.Ser269Thr	c.806G>C	0.18	0.022	58.0	C	GMAF=0.1412:AMAF=0.2191:EMAF=0.0978	0.05		Benign	7226575	rs760900241:rs6472		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.98														
chr6:39927671	SNV	T	1	C/C	PASS	3.801893963205613E-11	104.2		11	T=0,C=11	T=0.0,C=1.0	100.00	0.377	2		MOCS1	NM_001358530.2	MOCS1:intronic:NM_001358530.2	unknown			p.?	c.124-216A>G				C				Benign		rs3008822		(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MOCS1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MOCS1)(dui:D008659;dis:Metabolic Diseases;g:MOCS1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MOCS1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MOCS1)(dui:D008664;dis:Metal Metabolism, Inborn Errors;g:MOCS1)			603707	PF01967:PF04055:PF06463:PF13353	-0.93														
chr6:49435569	SNV	T	1	C/C	PASS	1.2445146117713818E-152	1519.05		156	T=1,C=155	T=0.0064,C=0.9936	99.36	0.451	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	GTA	12	p.Ile671Val	c.2011A>G	1.0	0.0	29.0	C	GMAF=0.393:AMAF=0.4122:EMAF=0.3833	0.25		Benign	4004063	rs8589		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	3.9														
chr6:49447735	SNV	C	1	C/T	PASS	8.50354471999803E-17	160.704		64	C=31,T=33	C=0.4844,T=0.5156	51.56	0.086	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	ACT	8	p.Ala499Thr	c.1495G>A	1.0	0.003	58.0	T	GMAF=0.1033:AMAF=0.0988:EMAF=0.1057	0.1		Benign/Likely benign	6351958	rs2229385		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.42														
chr6:49457808	SNV	C	1	T/T	PASS	4.5394161665018465E-151	1503.43		152	C=0,T=152	C=0.0,T=1.0	100.00	0.449	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	synonymous	AAA	3	p.Lys212=	c.636G>A				T	GMAF=0.3984:AMAF=0.4274:EMAF=0.3836	0.39		Benign	6350580	rs2229384		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.67														
chr6:80107031	SNV	T	1	T/C	PASS	2.287178184531505E-24	236.407		77	T=33,C=44	T=0.4286,C=0.5714	57.14	0.388	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.196+142T>C				C						rs35447745		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.0														
chr6:80127522	SNV	A	1	A/G	PASS	5.830422138432893E-23	222.343		134	A=77,G=57	A=0.5746,G=0.4254	42.54	0.388	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.197-25A>G				G	GMAF=0.323:AMAF=0.1148:EMAF=0.4297			Benign		rs9448893		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.45														
chr6:80127525	INDEL	ATTTTTTTTTTG	1	ATTTTTTTTTTG/ATTTTTTTTTT	PASS	3.2553673247163567E-24	234.874		127	ATTTTTTTTTTG=69,ATTTTTTTTTG=1,ATTTTTTTTTT=44,ATTTTTTTTTTT=13,ATTTTTTTTTTTG=0	ATTTTTTTTTTG=0.5433,ATTTTTTTTTG=0.0079,ATTTTTTTTTT=0.3465,ATTTTTTTTTTT=0.1024,ATTTTTTTTTTTG=0.0	ATTTTTTTTTG=0.79,ATTTTTTTTTT=34.65,ATTTTTTTTTTT=10.24,ATTTTTTTTTTTG=0.00	0.006:0.482:0.032	10,1,1,10		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.197-11delG				T				Benign		rs201800966:rs9448894:rs749742327:rs1554183990:rs759961267:rs774084435:rs1562068944:rs200609312:rs1266801799		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.07,0.15,0.48,-0.26,-1.12,0.05,0.23,0.45,3.1,0.51,1.6,-0.22														
chr6:80272984	SNV	G	1	G/A	PASS	2.270387567758496E-38	376.439		175	G=90,A=85	G=0.5143,A=0.4857	48.57	0.403	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.952-151G>A				A						rs9341811		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.85														
chr7:117548628	INDEL	GTT	2	GTT/GTTGT	PASS	1.0908122336864582E-7	69.6225		34	GTT=19,GTGT=0,GTTGT=15,GT=0,TGT=0	GTT=0.5588,GTGT=0.0,GTTGT=0.4412,GT=0.0,TGT=0.0	GTGT=0.00,GTTGT=44.12,GT=0.00,TGT=0.00	0.071:0.002:0.003	0,0,7,1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-12_1210-11insTG|	|	|	|	TTG|	GMAF=0.1229:AMAF=0.102:EMAF=0.1336			Likely benign		rs1230197379:rs4148705:rs73715573:rs1584793368:rs1584793324:rs765376630:rs1584793341:rs756031917:rs551227135:rs750294275:rs10229820:rs1805177:rs1399483116		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.46,0.56,0.24														
chr7:117610711	SNV	A	1	A/T	PASS	1.3161336711857372E-25	248.807		91	A=42,T=49	A=0.4615,T=0.5385	53.85	0.038	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.3139+42A>T				T	GMAF=0.0381:AMAF=0.1021:EMAF=0.0054			Benign		rs28517401		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.17														
chr7:117611489	SNV	T	1	T/C	PASS	1.6413454667021253E-42	417.848		129	T=53,C=76	T=0.4109,C=0.5891	58.91	0.121	2		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.3140-92T>C				C				Benign		rs4148717		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-1.79														
chr7:117642590	SNV	A	1	A/G	PASS	6.365023332473091E-32	311.962		98	A=41,G=57	A=0.4184,G=0.5816	58.16	0.068	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	CCG	23	p.Pro1290=	c.3870A>G				G	GMAF=0.0707:AMAF=0.1509:EMAF=0.0297			Benign		rs1800130		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.24														
chr7:117642710	SNV	T	1	T/G	PASS	8.031561699226598E-28	270.952		108	T=52,G=56	T=0.4815,G=0.5185	51.85	0.039	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.3873+117T>G				G						rs10155917:rs1562923376		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.47														
chr7:117667054	SNV	G	1	G/A	PASS	1.1678847834896357E-43	429.326		178	G=87,A=91	G=0.4888,A=0.5112	51.12	0.186	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	CAA	27	p.Gln1463=	c.4389G>A				A	GMAF=0.2259:AMAF=0.2444:EMAF=0.2164	0.11		Benign/Likely benign	3762339	rs1800136:rs1584850283		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.01														
chr8:142875392	SNV	A	1	A/C	PASS	6.092562597496569E-20	192.152		106	A=59,C=47	A=0.5566,C=0.4434	44.34	0.259	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-80T>G				C						rs6395		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.29														
chr8:142875509	SNV	T	1	T/C	PASS	1.3489628825916615E-27	268.7		112	T=55,C=57	T=0.4911,C=0.5089	50.89	0.24	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-197A>G				C						rs6392		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.07														
chr8:142876102	SNV	A	1	A/T	PASS	4.891026321245946E-15	143.106		76	A=42,T=34	A=0.5526,T=0.4474	44.74	0.011	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.954+139T>A				T						rs62524999		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-1.34														
chr8:142876440	SNV	G	1	G/A	PASS	5.7743087271398296E-43	422.385		183	G=91,A=92	G=0.4973,A=0.5027	50.27	0.315	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.800-45C>T				A	GMAF=0.4197:AMAF=0.3926:EMAF=0.4336					rs7822986		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-1.98														
chr8:142876563	SNV	A	1	A/C	PASS	3.051616820082477E-8	75.1547		43	A=25,C=18	A=0.5814,C=0.4186	41.86	0.382	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.799+119T>G				C						rs10956991		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.19														
chr8:142877011	SNV	C	1	C/T	PASS	5.228775553134403E-26	252.816		178	C=107,T=71	C=0.6011,T=0.3989	39.89	0.436	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.595+12G>A				T	GMAF=0.4845:AMAF=0.3736:EMAF=0.4587			Benign		rs6387		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.01														
chr8:142879181	SNV	G	1	G/A	PASS	6.447628406439212E-16	151.906		75	G=40,A=35	G=0.5333,A=0.4667	46.67	0.303	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	GAT	2	p.Asp82=	c.246C>T				A	GMAF=0.3283:AMAF=0.1117:EMAF=0.4393	0.01		Benign	4162721	rs5283		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.46														
chr8:142879589	SNV	T	1	T/C	PASS	9.896918638691065E-16	150.045		68	T=35,C=33	T=0.5147,C=0.4853	48.53	0.416	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	CTG	1	p.Leu75=	c.225A>G				C	GMAF=0.4923:AMAF=0.4424:EMAF=0.4588	0.05		Benign	6338105	rs6410		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.64														
chr10:102831425	SNV	G	1	G/T	PASS	3.800143529415847E-34	334.202		159	G=83,T=76	G=0.522,T=0.478	47.80	0.142	2		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1243+83C>A				T						rs284849		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.16														
chr10:102837224	SNV	G	1	G/A	PASS	3.5416040042646396E-32	314.508		160	G=86,A=74	G=0.5375,A=0.4625	46.25	0.443	1		CYP17A1	NM_000102.4	CYP17A1:exonic:NM_000102.4	synonymous	CAT	1	p.His46=	c.138C>T				A	GMAF=0.3949:AMAF=0.3645:EMAF=0.4105	0.02		Benign	3751500	rs6162		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.11														
chr11:5226496	SNV	G	1	G/A	PASS	2.4065783201116014E-20	196.186		96	G=51,A=45	G=0.5313,A=0.4688	46.88	0.099	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+81C>T				A				Benign		rs7946748		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.45														
chr11:5226503	SNV	A	1	A/C	PASS	2.6680870811543716E-23	225.738		95	A=47,C=48	A=0.4947,C=0.5053	50.53	0.369	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+74T>G				C				Benign		rs7480526		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	0.17														
chr11:5226561	SNV	C	1	C/G	PASS	1.8901662311868938E-24	237.235		99	C=49,G=50	C=0.4949,G=0.5051	50.51	0.28	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+16G>C				G	GMAF=0.1491:AMAF=0.1297:EMAF=0.159			Benign/Likely benign		rs10768683		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-3.19														
chr11:5227013	SNV	A	1	A/G	PASS	4.927197832116125E-40	393.074		175	A=88,G=87	A=0.5029,G=0.4971	49.71	0.286	1		HBB	NM_000518.5	HBB:exonic:NM_000518.5	synonymous	CAC	1	p.His3=	c.9T>C				G	GMAF=0.1513:AMAF=0.1361:EMAF=0.1591	0.1		Benign	6484194	rs713040:rs63750898:rs63750407		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.89														
chr11:66852947	SNV	G	1	G/A	PASS	1.4561294986160562E-19	188.368		70	G=33,A=37	G=0.4714,A=0.5286	52.86		3		PC	NM_001040716.2	PC:intronic:NM_001040716.2	unknown			p.?	c.1514-111C>T				A						rs1228166786		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PC)(dui:D008659;dis:Metabolic Diseases;g:PC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PC)(dui:D030342;dis:Genetic Diseases, Inborn;g:PC)(dui:D009422;dis:Nervous System Diseases;g:PC)(dui:D008661;dis:Metabolism, Inborn Errors;g:PC)(dui:D002493;dis:Central Nervous System Diseases;g:PC)(dui:D001927;dis:Brain Diseases;g:PC)(dui:D001928;dis:Brain Diseases, Metabolic;g:PC)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:PC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PC)(dui:D028361;dis:Mitochondrial Diseases;g:PC)(dui:D015324;dis:Pyruvate Carboxylase Deficiency Disease;g:PC)(dui:D015323;dis:Pyruvate Metabolism, Inborn Errors;g:PC)(dui:D009369;dis:Neoplasms;g:PC)(dui:D009370;dis:Neoplasms by Histologic Type;g:PC)(dui:D007154;dis:Immune System Diseases;g:PC)(dui:D004700;dis:Endocrine System Diseases;g:PC)(dui:D044882;dis:Glucose Metabolism Disorders;g:PC)(dui:D004066;dis:Digestive System Diseases;g:PC)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:PC)(dui:D003920;dis:Diabetes Mellitus;g:PC)(dui:D007160;dis:Immunoproliferative Disorders;g:PC)(dui:D008107;dis:Liver Diseases;g:PC)(dui:D008206;dis:Lymphatic Diseases;g:PC)(dui:D008103;dis:Liver Cirrhosis;g:PC)(dui:D008223;dis:Lymphoma;g:PC)(dui:D008232;dis:Lymphoproliferative Disorders;g:PC)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:PC)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:PC)(dui:D016393;dis:Lymphoma, B-Cell;g:PC)(dui:D002051;dis:Burkitt Lymphoma;g:PC)	5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal:Pyruvic acid:Biotin	GO:0006094:GO:0042802:GO:0009374:GO:0044794:GO:0005524:GO:0010629:GO:0019074:GO:0005515:GO:0006768:GO:0044791:GO:0004736:GO:0005737:GO:0005759:GO:0046872:GO:0005739:GO:0006629:GO:0005829:GO:0006090	608786:612283	PF00682:PF07478:PF00364:PF02786:PF02785:PF00289:PF02436	-1.43														
chr11:68780792	SNV	C	1	A/A	PASS	2.1777097723532704E-178	1776.62		178	C=0,A=178	C=0.0,A=1.0	100.00	0.107	1		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.1353-47G>T				A	GMAF=0.0881:AMAF=0.1534:EMAF=0.0546					rs750602950:rs3019576		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	-0.99														
chr11:68781872	SNV	A	1	G/G	PASS	3.698281797802523E-262	2614.32		276	A=4,G=272	A=0.0145,G=0.9855	98.55	0.107	3		CPT1A	NM_001876.4	CPT1A:exonic:NM_001876.4	synonymous	TTC	11	p.Phe417=	c.1251T>C				G	GMAF=0.088:AMAF=0.153:EMAF=0.0547			Benign		rs755361411:rs2228502		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.3														
chr11:108121598	SNV	T	1	T/A	PASS	1.9010782799232995E-24	237.21		99	T=49,A=50	T=0.4949,A=0.5051	50.51	0.314	1		ACAT1	NM_000019.4	ACAT1:utr_5:NM_000019.4	unknown		1	p.?	c.-9T>A				A	GMAF=0.1976:AMAF=0.0792:EMAF=0.2582			Benign		rs3741055:rs34512802		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-1.31														
chr11:108121619	SNV	G	1	G/C	PASS	2.9376496519615307E-25	245.32		100	G=49,C=51	G=0.49,C=0.51	51.00	0.332	2		ACAT1	NM_000019.4	ACAT1:exonic:NM_000019.4	missense	CCG	1	p.Ala5Pro	c.13G>C	0.01	0.61	27.0	C	GMAF=0.2097:AMAF=0.1224:EMAF=0.2544	0.24		Benign	3752118	rs3741056:rs1591350265		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.17														
chr11:108141783	INDEL	A	4	AAAGT/AAAGT	PASS	5.069907082746858E-133	1322.95		140	A=1,AAAGT=139	A=0.0071,AAAGT=0.9929	99.29	0.007:0.003	5		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.826+83_826+84insAAGT				AAAGT				Benign		rs10682490:rs34420529		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	1.38														
chr11:108142366	SNV	A	1	A/G	PASS	9.587381298845329E-32	310.183		170	A=94,G=76	A=0.5529,G=0.4471	44.71	0.191	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.827-71A>G				G						rs10890818		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.34														
chr11:108142634	SNV	C	1	C/T	PASS	1.631924265105627E-27	267.873		96	C=43,T=53	C=0.4479,T=0.5521	55.21	0.262	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.940+84C>T				T						rs12794010		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	0.95														
chr11:108144072	SNV	C	1	C/T	PASS	7.169683755804187E-19	181.445		57	C=24,T=33	C=0.4211,T=0.5789	57.89	0.308	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.1005+25C>T				T	GMAF=0.2437:AMAF=0.0902:EMAF=0.3222					rs10890819		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.31														
chr12:56004670	SNV	G	1	C/C	PASS	1.4521116175876677E-167	1668.38		171	G=0,C=171	G=0.0,C=1.0	100.00	0.237	2		SUOX	NM_001032387.2	SUOX:exonic:NM_001032387.2	synonymous	TCC	4	p.Ser427=	c.1281G>C				C	GMAF=0.2642:AMAF=0.3768:EMAF=0.0802			Benign		rs1565799723:rs773115		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:SUOX)(dui:D008659;dis:Metabolic Diseases;g:SUOX)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:SUOX)(dui:D030342;dis:Genetic Diseases, Inborn;g:SUOX)(dui:D008661;dis:Metabolism, Inborn Errors;g:SUOX)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:SUOX)(dui:D007154;dis:Immune System Diseases;g:SUOX)(dui:D004700;dis:Endocrine System Diseases;g:SUOX)(dui:D001327;dis:Autoimmune Diseases;g:SUOX)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:SUOX)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:SUOX)(dui:D009140;dis:Musculoskeletal Diseases;g:SUOX)(dui:D009369;dis:Neoplasms;g:SUOX)(dui:D003240;dis:Connective Tissue Diseases;g:SUOX)(dui:D003560;dis:Cysts;g:SUOX)(dui:D006058;dis:Gonadal Disorders;g:SUOX)(dui:D007592;dis:Joint Diseases;g:SUOX)(dui:D012216;dis:Rheumatic Diseases;g:SUOX)(dui:D052776;dis:Female Urogenital Diseases;g:SUOX)(dui:D001168;dis:Arthritis;g:SUOX)(dui:D001172;dis:Arthritis, Rheumatoid;g:SUOX)(dui:D005831;dis:Genital Diseases, Female;g:SUOX)(dui:D010048;dis:Ovarian Cysts;g:SUOX)(dui:D010049;dis:Ovarian Diseases;g:SUOX)(dui:D000291;dis:Adnexal Diseases;g:SUOX)(dui:D011085;dis:Polycystic Ovary Syndrome;g:SUOX)	{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum	GO:0005758:GO:0005515:GO:0006790:GO:0070221:GO:0005759:GO:0005739:GO:0008482:GO:0030151:GO:0020037:GO:0043546	606887	PF00173:PF00174:PF03404	-1.35														
chr12:102843690	SNV	G	1	C/C	PASS	4.8305880203980146E-257	2563.16		257	G=0,C=257	G=0.0,C=1.0	100.00	0.16	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CTG	12	p.Leu385=	c.1155C>G				C	GMAF=0.1728:AMAF=0.1959:EMAF=0.161			Benign		rs772897		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.1														
chr12:102846852	SNV	C	1	C/A	PASS	1.2705741052085498E-28	278.96		155	C=86,A=69	C=0.5548,A=0.4452	44.52	0.27	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.969+43G>T				A	GMAF=0.3666:AMAF=0.2685:EMAF=0.4169			Benign		rs1522306		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.11														
chr12:102852922	SNV	C	1	C/T	PASS	1.5736204832404641E-34	338.031		131	C=62,T=69	C=0.4733,T=0.5267	52.67	0.315	2		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	GTA	8	p.Val245=	c.735G>A				T	GMAF=0.1815:AMAF=0.0556:EMAF=0.246	0.39		Benign,Likely pathogenic	5618696	rs1042503:rs796052017		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.25														
chr12:102855146	SNV	C	1	T/T	PASS	3.863669770540595E-132	1314.13		133	C=0,T=133	C=0.0,T=1.0	100.00	0.454	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CAA	7	p.Gln232=	c.696G>A				T	GMAF=0.3465:AMAF=0.2317:EMAF=0.4052	0.02		Benign	7233325	rs1126758		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-2.59														
chr12:102855386	SNV	C	1	C/T	PASS	2.6952558665041326E-52	515.694		185	C=83,T=102	C=0.4486,T=0.5514	55.14	0.235	1		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.510-54G>A				T				Benign		rs2251905		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-4.26														
chr12:102877415	SNV	G	1	G/A	PASS	8.943345319325571E-24	230.485		75	G=32,A=43	G=0.4267,A=0.5733	57.33	0.294	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.441+47C>T				A	GMAF=0.3828:AMAF=0.2851:EMAF=0.4329			Benign		rs1718301		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.57														
chr12:102917009	SNV	G	1	G/A	PASS	1.601031954667331E-22	217.956		66	G=27,A=39	G=0.4091,A=0.5909	59.09	0.364	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.60+62C>T				A	GMAF=0.3771:AMAF=0.487:EMAF=0.318			Benign		rs1522296		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.51														
chr12:102917211	SNV	G	1	G/A	PASS	4.1209751909733207E-26	253.85		119	G=62,A=57	G=0.521,A=0.479	47.90	0.028	2		PAH	NM_001354304.2	PAH:utr_5:NM_001354304.2	unknown		2	p.?	c.-81C>T				A				Benign		rs7954004		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	0.44														
chr12:109573489	SNV	C	1	C/A	PASS	4.456562483975042E-30	293.51		144	C=76,A=68	C=0.5278,A=0.4722	47.22	0.004	1		MMAB|MVK	NM_052845.4|NM_001114185.3	MMAB:utr_5:NM_052845.4|MVK:upstream:NM_001114185.3	unknown|unknown	|	1|	p.?|p.?	c.-9G>T|c.-1334C>A	|	|	|	A|A				Conflicting interpretations of pathogenicity		rs554831769		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAB)(dui:NBS2;dis:Core Conditions;g:MMAB)(dui:NBS9;dis:Organic Acid Condition;g:MMAB)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAB)(dui:D008659;dis:Metabolic Diseases;g:MMAB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAB)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAB)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MVK)(dui:D030342;dis:Genetic Diseases, Inborn;g:MVK)(dui:D009422;dis:Nervous System Diseases;g:MVK)(dui:D056660;dis:Hereditary Autoinflammatory Diseases;g:MVK)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MVK)(dui:D008659;dis:Metabolic Diseases;g:MVK)(dui:D002493;dis:Central Nervous System Diseases;g:MVK)(dui:D001927;dis:Brain Diseases;g:MVK)(dui:D008661;dis:Metabolism, Inborn Errors;g:MVK)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MVK)(dui:D007154;dis:Immune System Diseases;g:MVK)(dui:D006402;dis:Hematologic Diseases;g:MVK)(dui:D007160;dis:Immunoproliferative Disorders;g:MVK)(dui:D001796;dis:Blood Protein Disorders;g:MVK)(dui:D001928;dis:Brain Diseases, Metabolic;g:MVK)(dui:D006942;dis:Hypergammaglobulinemia;g:MVK)(dui:D018901;dis:Peroxisomal Disorders;g:MVK)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MVK)(dui:D054078;dis:Mevalonate Kinase Deficiency;g:MVK)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MVK)(dui:D012871;dis:Skin Diseases;g:MVK)(dui:D012873;dis:Skin Diseases, Genetic;g:MVK)(dui:D007642;dis:Keratosis;g:MVK)(dui:D017499;dis:Porokeratosis;g:MVK)(dui:D009461;dis:Neurologic Manifestations;g:MVK)(dui:D004066;dis:Digestive System Diseases;g:MVK)(dui:D010146;dis:Pain;g:MVK)(dui:D009369;dis:Neoplasms;g:MVK)(dui:D008107;dis:Liver Diseases;g:MVK)(dui:D009371;dis:Neoplasms by Site;g:MVK)(dui:D004067;dis:Digestive System Neoplasms;g:MVK)(dui:D008113;dis:Liver Neoplasms;g:MVK)(dui:D009370;dis:Neoplasms by Histologic Type;g:MVK)(dui:D009140;dis:Musculoskeletal Diseases;g:MVK)(dui:D007592;dis:Joint Diseases;g:MVK)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MVK)(dui:D002277;dis:Carcinoma;g:MVK)(dui:D006528;dis:Carcinoma, Hepatocellular;g:MVK)(dui:D000230;dis:Adenocarcinoma;g:MVK)(dui:D018771;dis:Arthralgia;g:MVK)(dui:D005076;dis:Exanthema;g:MVK)	Farnesyl thiopyrophosphate:Cyanocobalamin	GO:0042802:GO:0050728:GO:0006695:GO:0004496:GO:0009235:GO:0008299:GO:0000287:GO:0005524:GO:0005777:GO:0005515:GO:0045540:GO:0005759:GO:0019287:GO:0043231:GO:0031419:GO:0008817:GO:0005829:GO:0016310	251170:607568	PF01923	-1.22														
chr12:120737096	SNV	T	1	C/C	PASS	1.2274392311584437E-106	1059.11		109	T=1,C=108	T=0.0092,C=0.9908	99.08	0.409	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGC	3	p.Arg107=	c.321T>C				C	GMAF=0.4932:AMAF=0.3756:EMAF=0.4466	0.28		Benign	3765623	rs1064795254:rs3914		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.18														
chr12:120737135	SNV	C	1	C/T	PASS	5.82773774796363E-28	272.345		103	C=48,T=55	C=0.466,T=0.534	53.40	0.076	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	AAT	3	p.Asn120=	c.360C>T				T	GMAF=0.0069:AMAF=0.0041:EMAF=0.0084	0.02		Benign	1359402	rs76543640		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-2.97														
chr12:120738181	SNV	T	1	C/C	PASS	3.1405086938763193E-137	1365.03		137	T=0,C=137	T=0.0,C=1.0	100.00	0.406	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.625-99T>C				C						rs555404		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-2.88														
chr12:120738280	SNV	G	1	G/A	PASS	2.016043970664317E-65	646.955		159	G=54,A=105	G=0.3396,A=0.6604	66.04	0.182	3		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	missense	AGC	6	p.Gly209Ser	c.625G>A	0.01	0.664	56.0	A	GMAF=0.1968:AMAF=0.0645:EMAF=0.2647	0.97		Benign/Likely benign	3752964	rs1799958		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	9.56														
chr12:120738490	SNV	C	1	C/T	PASS	3.6182619073243023E-16	154.415		110	C=67,T=43	C=0.6091,T=0.3909	39.09	0.075	3		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.795+40C>T				T	GMAF=0.0068:AMAF=0.0034:EMAF=0.0085					rs17848090		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.76														
chr12:120738876	SNV	C	1	T/T	PASS	1.3215999087792046E-86	858.789		87	C=0,T=87	C=0.0,T=1.0	100.00	0.327	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGT	8	p.Arg330=	c.990C>T				T	GMAF=0.408:AMAF=0.1235:EMAF=0.4462	0.02		Benign	4146720	rs796051906:rs1555244280:rs3915		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.49														
chr12:120738967	SNV	C	1	C/T	PASS	1.655769963469526E-11	107.81		61	C=35,T=26	C=0.5738,T=0.4262	42.62	0.075	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.1029+52C>T				T	GMAF=0.0054:AMAF=0.0027:EMAF=0.0069					rs2071266		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.87														
chr12:120739469	SNV	G	1	G/C	PASS	1.405400164387624E-26	258.522		87	G=38,C=49	G=0.4368,C=0.5632	56.32	0.193	2		ACADS	NM_000017.4	ACADS:utr_3:NM_000017.4	unknown		10	p.?	c.*21G>C				C	GMAF=0.1979:AMAF=0.0849:EMAF=0.2557			Benign		rs3916		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.11														
chr12:120739563	SNV	G	1	G/A	PASS	1.1371035097106448E-17	169.442		76	G=39,A=37	G=0.5132,A=0.4868	48.68	0.075	3		ACADS	NM_000017.4	ACADS:utr_3:NM_000017.4	unknown		10	p.?	c.*115G>A				A				Benign		rs2229534		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.87														
chr13:20189202	SNV	C	1	T/T	PASS	1.030386120441696E-286	2859.87		294	C=2,T=292	C=0.0068,T=0.9932	99.32	0.027	1		GJB2	NM_004004.6	GJB2:exonic:NM_004004.6	missense	CAC	2	p.Arg127His	c.380G>A			29.0	T	GMAF=0.0023:AMAF=9.0E-4:EMAF=0.003	0.45		Conflicting interpretations of pathogenicity	5052088	rs111033196		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GJB2)(dui:NBS2;dis:Core Conditions;g:GJB2)(dui:NBS14;dis:Other Disorder;g:GJB2)(dui:NBS75;dis:Hearing Loss;g:GJB2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GJB2)(dui:D000013;dis:Congenital Abnormalities;g:GJB2)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:GJB2)(dui:D012871;dis:Skin Diseases;g:GJB2)(dui:D009422;dis:Nervous System Diseases;g:GJB2)(dui:D009461;dis:Neurologic Manifestations;g:GJB2)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:GJB2)(dui:D004427;dis:Ear Diseases;g:GJB2)(dui:D012678;dis:Sensation Disorders;g:GJB2)(dui:D006311;dis:Hearing Disorders;g:GJB2)(dui:D034381;dis:Hearing Loss;g:GJB2)(dui:D007642;dis:Keratosis;g:GJB2)(dui:D006319;dis:Hearing Loss, Sensorineural;g:GJB2)(dui:D030342;dis:Genetic Diseases, Inborn;g:GJB2)(dui:D000015;dis:Abnormalities, Multiple;g:GJB2)(dui:D012873;dis:Skin Diseases, Genetic;g:GJB2)(dui:D009140;dis:Musculoskeletal Diseases;g:GJB2)(dui:D007645;dis:Keratoderma, Palmoplantar;g:GJB2)(dui:D006226;dis:Hand Deformities;g:GJB2)(dui:D009139;dis:Musculoskeletal Abnormalities;g:GJB2)(dui:D006228;dis:Hand Deformities, Congenital;g:GJB2)(dui:D017880;dis:Limb Deformities, Congenital;g:GJB2)(dui:D038062;dis:Upper Extremity Deformities, Congenital;g:GJB2)(dui:D012868;dis:Skin Abnormalities;g:GJB2)(dui:D007232;dis:Infant, Newborn, Diseases;g:GJB2)(dui:D007057;dis:Ichthyosis;g:GJB2)(dui:D005128;dis:Eye Diseases;g:GJB2)(dui:D003638;dis:Deafness;g:GJB2)(dui:D003316;dis:Corneal Diseases;g:GJB2)(dui:D007634;dis:Keratitis;g:GJB2)(dui:D009369;dis:Neoplasms;g:GJB2)(dui:D009371;dis:Neoplasms by Site;g:GJB2)(dui:D004066;dis:Digestive System Diseases;g:GJB2)(dui:D017444;dis:Skin Diseases, Papulosquamous;g:GJB2)(dui:D011565;dis:Psoriasis;g:GJB2)(dui:D004700;dis:Endocrine System Diseases;g:GJB2)(dui:D003240;dis:Connective Tissue Diseases;g:GJB2)(dui:D012874;dis:Skin Diseases, Infectious;g:GJB2)(dui:D002481;dis:Cellulitis;g:GJB2)(dui:D012878;dis:Skin Neoplasms;g:GJB2)(dui:D013543;dis:Sweat Gland Diseases;g:GJB2)(dui:D016575;dis:Hidradenitis;g:GJB2)(dui:D017192;dis:Skin Diseases, Bacterial;g:GJB2)(dui:D017497;dis:Hidradenitis Suppurativa;g:GJB2)		GO:0016328:GO:0048839:GO:1903763:GO:0032570:GO:0046677:GO:1905867:GO:0046697:GO:0005793:GO:0044752:GO:0005921:GO:0007605:GO:0005887:GO:0032526:GO:0002931:GO:0005922:GO:0071377:GO:0005509:GO:1990349:GO:0097449:GO:0005829:GO:0042802:GO:0055085:GO:0007267:GO:0005243:GO:0007568:GO:0005886:GO:0005515:GO:0048471:GO:0044297:GO:0010644:GO:0032355:GO:0016264:GO:0034599:GO:0032496:GO:0071549	121011	PF00029	0.67														
chr13:100111917	SNV	T	1	T/A	PASS	2.123244462000228E-18	176.73		77	T=39,A=38	T=0.5065,A=0.4935	49.35	0.003	4		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.0031:AMAF=0.0011:EMAF=0.0041					rs184412459		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.19														
chr13:100268802	SNV	A	1	G/G	PASS	2.419357236607628E-92	916.163		114	A=9,G=105	A=0.0789,G=0.9211	92.11	0.084	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.0825:AMAF=0.2419:EMAF=8.0E-4			Benign		rs4306370		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.76														
chr13:100368441	SNV	A	1	A/G	PASS	2.867477375581313E-25	245.425		131	A=72,G=59	A=0.5496,G=0.4504	45.04	0.447	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.3177:AMAF=0.4921:EMAF=0.2284			Benign		rs9518061		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.28														
chr15:40407739	SNV	T	1	T/C	PASS	7.452465942515182E-46	451.277		165	T=74,C=91	T=0.4485,C=0.5515	55.15	0.352	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4044:AMAF=0.485:EMAF=0.3478			Benign		rs2289331		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		-1.6														
chr15:40407823	SNV	C	1	C/T	PASS	4.6601511170219E-35	343.316		108	C=45,T=63	C=0.4167,T=0.5833	58.33	0.473	2		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs10518693:rs1566932254:rs1219352520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.04														
chr15:40411410	SNV	A	1	G/G	PASS	2.7289777828079066E-136	1355.64		140	A=1,G=139	A=0.0071,G=0.9929	99.29	0.022	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2													Benign		rs4924466		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.1														
chr15:40412906	SNV	A	1	A/G	PASS	1.96426464587985E-44	437.068		171	A=81,G=90	A=0.4737,G=0.5263	52.63	0.317	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs2289330		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.42														
chr15:40412960	SNV	T	1	T/C	PASS	3.5334585410890315E-49	484.518		182	T=84,C=98	T=0.4615,C=0.5385	53.85	0.466	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.3293:AMAF=0.2031:EMAF=0.394			Benign		rs2289329		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.94														
chr15:40416223	SNV	A	1	A/G	PASS	5.800961725227047E-60	592.365		218	A=99,G=119	A=0.4541,G=0.5459	54.59	0.368	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4227:AMAF=0.4324:EMAF=0.3485			Benign		rs11070270		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.49														
chr15:76226005	INDEL	C	5	CCCTTA/CCCTTA	PASS	3.793149849736762E-111	1104.21		112	C=0,CCCTTA=112	C=0.0,CCCTTA=1.0	100.00	0.031	2		ETFA	NM_000126.4	ETFA:intronic:NM_000126.4	unknown			p.?	c.883-77_883-76insTAAGG				CCCTTA						rs11281932:rs112972949		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFA)(dui:NBS3;dis:Secondary Conditions;g:ETFA)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFA)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFA)(dui:D008659;dis:Metabolic Diseases;g:ETFA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFA)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFA)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFA)(dui:D028361;dis:Mitochondrial Diseases;g:ETFA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFA)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFA)(dui:D009140;dis:Musculoskeletal Diseases;g:ETFA)(dui:D007592;dis:Joint Diseases;g:ETFA)(dui:D012216;dis:Rheumatic Diseases;g:ETFA)(dui:D001168;dis:Arthritis;g:ETFA)(dui:D009369;dis:Neoplasms;g:ETFA)(dui:D009370;dis:Neoplasms by Histologic Type;g:ETFA)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:ETFA)(dui:D004066;dis:Digestive System Diseases;g:ETFA)(dui:D009371;dis:Neoplasms by Site;g:ETFA)(dui:D008107;dis:Liver Diseases;g:ETFA)(dui:D002277;dis:Carcinoma;g:ETFA)(dui:D000230;dis:Adenocarcinoma;g:ETFA)(dui:D004067;dis:Digestive System Neoplasms;g:ETFA)(dui:D008113;dis:Liver Neoplasms;g:ETFA)(dui:D010003;dis:Osteoarthritis;g:ETFA)(dui:D006528;dis:Carcinoma, Hepatocellular;g:ETFA)		GO:0033539:GO:0005515:GO:0005759:GO:0016491:GO:0050660:GO:0009055:GO:0005739:GO:0022904	608053	PF00766:PF01012	0.16														
chr15:80152950	SNV	G	1	G/C	PASS	1.4444416411067024E-14	138.403		43	G=18,C=25	G=0.4186,C=0.5814	58.14	0.186	5		FAH	NM_000137.4	FAH:upstream:NM_000137.4	unknown			p.?	c.-105G>C				C				Benign		rs112474268		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-2.77														
chr15:80153175	INDEL	GT	1	GT/G	PASS	0.010735938128960875	19.6916		24	GT=18,G=6	GT=0.75,G=0.25	25.00	0.031	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+41delT				G						rs777902403:rs57837512:rs767638459:rs762924131:rs558321563:rs756381638:rs752679360:rs1555440100:rs554422109:rs757176902		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.78,-0.07														
chr15:80159830	SNV	G	1	G/C	PASS	5.740371505656564E-7	62.4106		28	G=15,C=13	G=0.5357,C=0.4643	46.43	0.06	1		FAH	NM_000137.4	FAH:exonic:NM_000137.4	synonymous	CTC	3	p.Leu89=	c.267G>C				C	GMAF=0.0822:AMAF=0.0774:EMAF=0.0847	0.74		Benign	3999621	rs33929922		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	1.56														
chr15:80159926	SNV	G	1	G/A	PASS	2.1252009432736322E-12	116.726		41	G=19,A=22	G=0.4634,A=0.5366	53.66	0.36	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.314+49G>A				A	GMAF=0.3919:AMAF=0.3684:EMAF=0.404			Benign		rs1370273:rs1404883356		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.57														
chr15:80168182	SNV	A	1	G/G	PASS	2.7101916318907973E-242	2415.67		243	A=0,G=243	A=0.0,G=1.0	100.00	0.221	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.553+33A>G				G	GMAF=0.273:AMAF=0.2453:EMAF=0.2871			Benign		rs1545119		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.21														
chr15:80175247	SNV	G	1	G/C	PASS	6.305216450900441E-24	232.003		124	G=68,C=56	G=0.5484,C=0.4516	45.16	0.061	4		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.913+156G>C				C						rs79745256		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.46														
chr15:80175284	SNV	G	1	G/T	PASS	1.8138442808706253E-30	297.414		110	G=51,T=59	G=0.4636,T=0.5364	53.64	0.447	3		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.913+193G>T				T						rs1863768		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.01														
chr15:80180089	SNV	C	1	A/A	PASS	2.1777097723532705E-198	1976.62		198	C=0,A=198	C=0.0,A=1.0	100.00	0.33	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.961-35C>A				A	GMAF=0.406:AMAF=0.4737:EMAF=0.3713			Benign		rs2043691		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.01														
chr15:80180219	SNV	C	1	C/T	PASS	8.085371885255472E-12	110.923		67	C=39,T=28	C=0.5821,T=0.4179	41.79	0.06	1		FAH	NM_000137.4	FAH:exonic:NM_000137.4	synonymous	AGT	12	p.Ser352=	c.1056C>T				T	GMAF=0.0416:AMAF=0.0334:EMAF=0.0458	0.24		Benign	5619276	rs1801374:rs1292305529		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.69														
chr15:80186247	MNV	ACCCC	5	ACCCC/CTTTG	PASS	2.3856130399309183E-36	356.224		185	ACCCC=100,CTTTG=85	ACCCC=0.5405,CTTTG=0.4595	45.95	0.112	1		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*38ACCCC>CTTTG				CTTTG						rs3210172:rs1049181:rs374309326:rs751787251:rs370537299:rs199626920:rs377100715:rs369845634:rs386785740		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.95,0.27,0.04,0.13,0.06														
chr15:80186257	INDEL	AC	1	AC/A	PASS	9.382098755562886E-17	160.277		191	AC=101,A=90	AC=0.5288,A=0.4712	47.12	0.112	3		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*48AC>A				A	GMAF=0.1042:AMAF=0.0643:EMAF=0.1249			Likely benign		rs200464452:rs755736456:rs749985438		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.97,0.39														
chr15:80186303	SNV	T	1	T/C	PASS	4.8128242186760375E-39	383.176		181	T=94,C=87	T=0.5193,C=0.4807	48.07	0.113	2		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*94T>C				C				Benign		rs1049194		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.25														
chr16:71570009	SNV	C	1	A/A	PASS	5.511883123275998E-67	662.587		71	C=1,A=70	C=0.0141,A=0.9859	98.59	0.433	5		TAT|TAT-AS1	NM_000353.3|NR_103851.1	TAT:intronic:NM_000353.3|TAT-AS1:intronic_nc:NR_103851.1	unknown|	|	|	p.?|	c.1042-72G>T|	|	|	|	A|						rs172650:rs1413052063		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.63														
chr16:71573481	SNV	T	1	G/G	PASS	4.400479478359725E-97	963.565		97	T=0,G=97	T=0.0,G=1.0	100.00	0.414	1		TAT	NM_000353.3	TAT:intronic:NM_000353.3	unknown			p.?	c.408+58A>C				G	GMAF=0.3121:AMAF=0.229:EMAF=0.3482					rs2432520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.9														
chr17:7221421	INDEL	ACTGCCCTAGGTCAGGAA	17	ACTGCCCTAGGTCAGGAA/A	PASS	1.3586262458274846E-33	328.669		117	ACTGCCCTAGGTCAGGAA=53,A=64	ACTGCCCTAGGTCAGGAA=0.453,A=0.547	54.70	0.002	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-116_478-100delCTGCCCTAGGTCAGGAA				A						rs750835287:rs1567562754:rs80162838:rs78100429:rs535609436:rs35999860:rs147519793:rs1416225920:rs1184230081:rs1322109465:rs386795011:rs374828700:rs907034423:rs7503586:rs370388543:rs201760717:rs1031535036		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	-0.78,0.12,0.1,-0.17,-0.72,-1.03,-0.35,-0.01,-1.94,-0.18,1.36,-1.92,-0.66,0.83,-0.02,0.03,-0.03,-0.45														
chr17:7221449	SNV	T	1	T/C	PASS	1.127457032865187E-47	469.479		137	T=53,C=84	T=0.3869,C=0.6131	61.31	0.478	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-89T>C				C						rs77493353:rs1416225920:rs9646410:rs386795011:rs386795012:rs374828700:rs1567562793		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	0.0														
chr17:7224399	SNV	T	1	T/C	PASS	4.353113592296377E-15	143.612		81	T=46,C=35	T=0.5679,C=0.4321	43.21	0.48	1		ACADVL|DVL2	NM_000018.4|NM_004422.3	ACADVL:intronic:NM_000018.4|DVL2:downstream:NM_004422.3	unknown|unknown	|	|	p.?|p.?	c.1605+6T>C|c.*1466A>G	|	|	|	C|C	GMAF=0.4383:AMAF=0.4362:EMAF=0.3739	0.07		Benign	7228542	rs17671352:rs1064795676		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0016328:GO:0043507:GO:0016604:GO:0090179:GO:0061098:GO:0022007:GO:0051091:GO:0043621:GO:0007379:GO:0043547:GO:0004466:GO:0006635:GO:0033539:GO:0005109:GO:0045177:GO:0000062:GO:0048365:GO:0005829:GO:0031314:GO:0019901:GO:0019904:GO:0090103:GO:0150012:GO:0045334:GO:0090181:GO:0030855:GO:0005634:GO:0005515:GO:0005759:GO:0017099:GO:0034613:GO:0003151:GO:0005730:GO:0045944:GO:0005654:GO:0009409:GO:0007507:GO:0001843:GO:0044340:GO:0046322:GO:0031410:GO:0060070:GO:0060071:GO:0016235:GO:0045717:GO:0061024:GO:0042802:GO:0015980:GO:0006355:GO:1904886:GO:0042645:GO:0003995:GO:0090090:GO:0031966:GO:0050660:GO:0005737:GO:0001659:GO:0005739:GO:0001934:GO:0035329:GO:0030674:GO:0035567	609575:602151	PF02771:PF02770:PF00441:PF08028	-0.25														
chr19:12891586	SNV	G	1	G/C	PASS	3.51479500064306E-29	284.541		82	G=32,C=50	G=0.3902,C=0.6098	60.98	0.253	2		GCDH	NR_102317.1	GCDH:exonic_nc:NR_102317.1			3							GMAF=0.3233:AMAF=0.2298:EMAF=0.3639					rs1799918		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide		608801	PF02771:PF02770:PF00441:PF08028	0.59														
chr19:12897793	SNV	G	1	G/T	PASS	7.000031591309004E-51	501.549		247	G=130,T=117	G=0.5263,T=0.4737	47.37	0.25	7		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:downstream:NM_001105578.2	|unknown	|	10|	|p.?	|c.*1548C>A	|	|	|	|T	GMAF=0.3071:AMAF=0.2072:EMAF=0.3583	0.09		Benign	2816924:6039891:3756351	rs1060218:rs1486220652		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF00441:PF08028	-1.11														
chr19:12899706	SNV	A	1	G/G	PASS	2.1677041048196164E-128	1276.64		128	A=0,G=128	A=0.0,G=1.0	100.00	0.28	1		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:intronic:NM_001105578.2	|unknown	|	11|	|p.?	|c.612+298T>C	|	|	|	|G	GMAF=0.3611:AMAF=0.1756:EMAF=0.4546	0.11		Benign	7218541	rs8012		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF01442:PF00441:PF08028	0.32														
chr19:41397766	SNV	A	1	A/G	PASS	1.8984536566614943E-22	217.216		128	A=73,G=55	A=0.5703,G=0.4297	42.97	0.418	3		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-438T>C|c.-62A>G	|	|	|	G|G						rs892044		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.08														
chr19:41397770	SNV	A	1	G/G	PASS	1.0232929922807327E-129	1289.9		129	A=0,G=129	A=0.0,G=1.0	100.00	0.02	1		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-442T>C|c.-58A>G	|	|	|	G|G						rs892043		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.12														
chr19:41411106	INDEL	CT	1	CT/C	PASS	1.317831851279733E-4	38.8014		67	CT=35,C=32	CT=0.5224,C=0.4776	47.76		6		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.375+98delT				C						rs746587969		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-1.16,0.73														
chr19:41414039	SNV	A	1	A/C	PASS	2.053525026457146E-28	276.875		117	A=58,C=59	A=0.4957,C=0.5043	50.43	0.384	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.376-10A>C				C	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.01		Benign	4000746	rs3213861		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.51														
chr19:41422431	SNV	T	1	T/C	PASS	2.0960420931948805E-27	266.786		99	T=46,C=53	T=0.4646,C=0.5354	53.54	0.382	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.853+61T>C				C						rs284651		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-2.12														
chr19:41422747	SNV	C	1	C/T	PASS	9.815219132257598E-37	360.081		96	C=35,T=61	C=0.3646,T=0.6354	63.54	0.384	2		BCKDHA	NM_001164783.2	BCKDHA:exonic:NM_001164783.2	synonymous	TTT	7	p.Phe323=	c.969C>T				T	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.92		Benign	3933055	rs284652:rs112312448		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	2.87														
chr19:41422819	SNV	G	1	G/A	PASS	3.4135007294931178E-34	334.668		91	G=34,A=57	G=0.3736,A=0.6264	62.64	0.414	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+49G>A				A	GMAF=0.3565:AMAF=0.2855:EMAF=0.3929			Benign/Likely benign		rs284654		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-1.91														
chr19:41422860	SNV	C	1	C/T	PASS	1.7778699932105282E-31	307.501		146	C=76,T=70	C=0.5205,T=0.4795	47.95	0.386	2		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+90C>T				T						rs284655		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	0.58														
chr19:41424491	SNV	A	1	A/G	PASS	6.686517721976429E-21	201.748		102	A=55,G=47	A=0.5392,G=0.4608	46.08	0.383	1		BCKDHA|B3GNT8	NM_001164783.2|NM_198540.2	BCKDHA:exonic:NM_001164783.2|B3GNT8:downstream:NM_198540.2	synonymous|unknown	CTG|	9|	p.Leu406=|p.?	c.1218A>G|c.*1094T>C	|	|	|	G|G	GMAF=0.323:AMAF=0.1895:EMAF=0.3914	0.15		Benign	7239888	rs4674		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0009083:GO:0016758:GO:0008375:GO:0006486:GO:0008532:GO:0000139:GO:0005794:GO:0008376:GO:0003863:GO:0005515:GO:0070062:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0016262:GO:0016021:GO:0055114:GO:0016266:GO:0030311:GO:0016831	615357:608348	PF00676	0.76														
chr19:45529477	INDEL	CAG	2	CAG/C	PASS	7.789328145536732E-27	261.085		124	CAG=65,C=59	CAG=0.5242,C=0.4758	47.58	0.148	1		OPA3												GMAF=0.1345:AMAF=0.1308:EMAF=0.1363					rs1599947393:rs149252540:rs1599947386		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)			606580		-0.36,-0.32,4.25														
chr19:45529583	SNV	G	1	G/C	PASS	2.2620385397696104E-25	246.455		118	G=62,C=56	G=0.5254,C=0.4746	47.46	0.309	4		OPA3																	rs12971437		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)			606580		-0.72														
chr19:45553823	SNV	A	1	A/G	PASS	7.850548482379835E-56	551.051		231	A=113,G=118	A=0.4892,G=0.5108	51.08	0.233	1		OPA3	NM_025136.4	OPA3:exonic:NM_025136.4	synonymous	GCC	2	p.Ala77=	c.231T>C				G	GMAF=0.3174:AMAF=0.2398:EMAF=0.3572	0.09		Benign	439792	rs3826860		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580	PF07047	-0.93														
chr19:45584839	SNV	C	1	C/T	PASS	6.05898671138969E-35	342.176		125	C=57,T=68	C=0.456,T=0.544	54.40	0.072	3		OPA3	NM_025136.4	OPA3:upstream:NM_025136.4	unknown			p.?	c.-75G>A				T				Benign		rs45598532		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580		1.29														
chr19:51354484	SNV	G	1	G/A	PASS	5.054753713597958E-38	372.963		201	G=110,A=91	G=0.5473,A=0.4527	45.27	0.077	4		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.58-176C>T				A	GMAF=0.0605:AMAF=0.0445:EMAF=0.0687			Benign		rs79338777		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-2.72														
chr19:51354620	INDEL	C	6	C/CCCACAG	PASS	2.4093505913355045E-29	286.181		171	C=97,CCCACAG=74	C=0.5673,CCCACAG=0.4327	43.27	0.082	3		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.58-313_58-312insCTGTGG				CCCACAG	GMAF=0.0866:AMAF=0.2446:EMAF=0.005			Benign		rs61361626:rs1568468379:rs869162765		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-0.54														
chrX:30308866	SNV	C	1	T/T	PASS	8.402335139077027E-86	850.756		86	C=0,T=86	C=0.0,T=1.0	100.00	0.477	2		NR0B1	NM_000475.5	NR0B1:exonic:NM_000475.5	synonymous	CGA	1	p.Arg166=	c.498G>A				T	GMAF=0.2828:AMAF=0.4339:EMAF=0.1968	0.08		Benign	3759465	rs2269345		(dui:D004700;dis:Endocrine System Diseases;g:NR0B1)(dui:D006058;dis:Gonadal Disorders;g:NR0B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:NR0B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:NR0B1)(dui:D052776;dis:Female Urogenital Diseases;g:NR0B1)(dui:D052801;dis:Male Urogenital Diseases;g:NR0B1)(dui:D000013;dis:Congenital Abnormalities;g:NR0B1)(dui:D014564;dis:Urogenital Abnormalities;g:NR0B1)(dui:D012734;dis:Disorders of Sex Development;g:NR0B1)(dui:D006059;dis:Gonadal Dysgenesis;g:NR0B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:NR0B1)(dui:D000307;dis:Adrenal Gland Diseases;g:NR0B1)(dui:D007006;dis:Hypogonadism;g:NR0B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:NR0B1)(dui:D008659;dis:Metabolic Diseases;g:NR0B1)(dui:D000309;dis:Adrenal Insufficiency;g:NR0B1)(dui:D058490;dis:46, XY Disorders of Sex Development;g:NR0B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:NR0B1)(dui:D040181;dis:Genetic Diseases, X-Linked;g:NR0B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:NR0B1)(dui:D011629;dis:Puberty, Precocious;g:NR0B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:NR0B1)(dui:D047808;dis:Adrenogenital Syndrome;g:NR0B1)(dui:D006061;dis:Gonadal Dysgenesis, 46,XY;g:NR0B1)	Dexamethasone:Dexamethasone acetate	GO:0008584:GO:0033144:GO:0016607:GO:0034451:GO:0008104:GO:0060008:GO:0021854:GO:0006367:GO:0005654:GO:0000122:GO:0003723:GO:0045892:GO:0043231:GO:0032448:GO:0035258:GO:0030325:GO:0010894:GO:0019904:GO:0042803:GO:0007283:GO:0043433:GO:0008134:GO:0021983:GO:0042788:GO:0005634:GO:0030238:GO:0005515:GO:0000790:GO:0008406:GO:0005737:GO:0050682:GO:0003714:GO:0016020:GO:0035902:GO:0033327	300473	PF14046:PF00104	0.48														
chrX:154532293	SNV	G	1	G/A	PASS	2.8326962002808964E-15	145.478		88	G=51,A=37	G=0.5795,A=0.4205	42.05		2		G6PD	NM_001042351.3	G6PD:intronic:NM_001042351.3	unknown			p.?	c.1365-13C>T				A	GMAF=0.3923:AMAF=0.1523:EMAF=0.1327					rs2071429		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-0.82														
chrX:154532439	SNV	A	1	A/G	PASS	8.655656238626578E-42	410.627		232	A=129,G=103	A=0.556,G=0.444	44.40		1		G6PD	NM_001042351.3	G6PD:exonic:NM_001042351.3	synonymous	TAC	11	p.Tyr437=	c.1311T>C				G	GMAF=0.1667:AMAF=0.2605:EMAF=0.1133			Benign		rs2230037		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-2.64														
chrX:154533044	SNV	C	1	C/T	PASS	2.0849709101237404E-52	516.809		164	C=68,T=96	C=0.4146,T=0.5854	58.54	0.002	1		G6PD	NM_001042351.3	G6PD:exonic:NM_001042351.3	missense	AAG	9	p.Glu317Lys	c.949G>A	0.05	0.837	56.0	T		0.92		Conflicting interpretations of pathogenicity	9230996	rs137852339		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	2.83														
chrX:154546029	SNV	T	1	T/G	PASS	4.892152651344186E-15	143.105		76	T=42,G=34	T=0.5526,G=0.4474	44.74	0.007	1		G6PD|IKBKG	NM_001042351.3|NM_001321396.3	G6PD:intronic:NM_001042351.3|IKBKG:intronic:NM_001321396.3	unknown|unknown	|	|	p.?|p.?	c.120+7A>C|c.-16+3642T>G	|	|	|	G|G	GMAF=3.0E-4:AMAF=8.0E-4:EMAF=0.0			Conflicting interpretations of pathogenicity		rs369904290		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IKBKG)(dui:D030342;dis:Genetic Diseases, Inborn;g:IKBKG)(dui:D000013;dis:Congenital Abnormalities;g:IKBKG)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:IKBKG)(dui:D012871;dis:Skin Diseases;g:IKBKG)(dui:D012873;dis:Skin Diseases, Genetic;g:IKBKG)(dui:D000015;dis:Abnormalities, Multiple;g:IKBKG)(dui:D012868;dis:Skin Abnormalities;g:IKBKG)(dui:D040181;dis:Genetic Diseases, X-Linked;g:IKBKG)(dui:D010859;dis:Pigmentation Disorders;g:IKBKG)(dui:D007184;dis:Incontinentia Pigmenti;g:IKBKG)(dui:D004476;dis:Ectodermal Dysplasia;g:IKBKG)(dui:D007154;dis:Immune System Diseases;g:IKBKG)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:IKBKG)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:IKBKG)(dui:D009140;dis:Musculoskeletal Diseases;g:IKBKG)(dui:D008206;dis:Lymphatic Diseases;g:IKBKG)(dui:D001847;dis:Bone Diseases;g:IKBKG)(dui:D001848;dis:Bone Diseases, Developmental;g:IKBKG)(dui:D008209;dis:Lymphedema;g:IKBKG)(dui:D010009;dis:Osteochondrodysplasias;g:IKBKG)(dui:D010026;dis:Osteosclerosis;g:IKBKG)(dui:D010022;dis:Osteopetrosis;g:IKBKG)(dui:D009369;dis:Neoplasms;g:IKBKG)(dui:D004066;dis:Digestive System Diseases;g:IKBKG)(dui:D008107;dis:Liver Diseases;g:IKBKG)(dui:D009371;dis:Neoplasms by Site;g:IKBKG)(dui:D005234;dis:Fatty Liver;g:IKBKG)(dui:D012140;dis:Respiratory Tract Diseases;g:IKBKG)(dui:D008171;dis:Lung Diseases;g:IKBKG)(dui:D012142;dis:Respiratory Tract Neoplasms;g:IKBKG)(dui:D008175;dis:Lung Neoplasms;g:IKBKG)(dui:D013899;dis:Thoracic Neoplasms;g:IKBKG)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:IKBKG)	Tarenflurbil:Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:AGRO100:Artenimol	GO:0032094:GO:0061052:GO:0008385:GO:0007254:GO:0006006:GO:0051092:GO:1990450:GO:0004345:GO:0042975:GO:0044877:GO:0000187:GO:0002479:GO:0006954:GO:0006955:GO:0002756:GO:0046982:GO:0043231:GO:0006915:GO:0019322:GO:0005829:GO:0010734:GO:0051403:GO:0016239:GO:0019904:GO:0065003:GO:0006098:GO:0006695:GO:0043276:GO:0014070:GO:0006974:GO:0005634:GO:0005515:GO:0031625:GO:0000151:GO:0046872:GO:0051650:GO:1990459:GO:0032991:GO:0046390:GO:0035666:GO:0010041:GO:0009051:GO:0034451:GO:0038095:GO:0043123:GO:0006740:GO:0043122:GO:0043523:GO:0009615:GO:0045944:GO:0009898:GO:0043249:GO:1904879:GO:0002223:GO:0005654:GO:0045471:GO:0070062:GO:0072686:GO:0006739:GO:0016032:GO:0070423:GO:0050852:GO:2000378:GO:0016579:GO:0042802:GO:0042803:GO:0000922:GO:1901215:GO:0007249:GO:0021762:GO:0005536:GO:0050661:GO:0051156:GO:0005737:GO:0070530:GO:0006749:GO:0045087:GO:0006629:GO:0016020:GO:0010803:GO:0034599:GO:0055114:GO:0070498	300248:305900	PF00479:PF02781	0.07														
